A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma

NCT03999684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: Tretinoin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]